Technology
Health
Biotechnology
Mereo BioPharma Group
$2.679876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$2.67
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.32 (-10.70%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell MREO and other stocks, options, ETFs, and crypto commission-free!
About
Mereo BioPharma Group Plc engages in the acquisition, development, and commercialization of therapeutics that aim to improve outcomes for patients with rare and specialty diseases. It focuses on the treatment of patients with osteogenesis imperfecta, alpha-1 antitrypsin deficiency, hypogonadotropic hypogonadism in obese men, and acute exacerbations of chronic obstructive pulmonary disease. Read More The company was founded by Denise Vera Pollard-Knight, Charles Sermon, Alastair MacKinnon, and John Richard in March 2015 and is headquartered in London, the United Kingdom.
Employees
37
Headquarters
London, Greater London
Founded
2015
Market Cap
53.13M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
9.34K
High Today
$2.99
Low Today
$2.55
Open Price
$2.99
Volume
29.38K
52 Week High
$8.48
52 Week Low
$2.55
Collections
Technology
Health
Biotechnology
Therapy
2019 IPO
UK
Europe
Female CEOs
Price Paid on Robinhood
191% Higher
Right Now
Average Price Paid
$0.9183
52 Week Low
$2.55
52 Week High
$8.48